In 2024, Sinopharm Group completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy) and Scope 3 (indirect emissions across the value chain).
However, Sinopharm Group has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.
| Metric (tCO2e) | 2024 | 2023 | 2022 | 2021-2019 |
|---|---|---|---|---|
Total Scope 1 | 48,785.71a | 54,715.05a | 52,434.34b | |
Total Scope 2 | ||||
Unspecified Calculation Method | 177,259.36a | 208,700.22a | 200,670.94b | |
Total Scope 3 | 318,336.83a | N/A | N/A | |
Total Scope 1 Revenue Intensity (tCO2e/$M) | 0.6091a | 0.6518a | 0.6612b |
You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"
Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.
In 2024, the total operational greenhouse gas (GHG) emissions of Sinopharm Group amounted to 226,045.07 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).a
Compared to 2023, the total operational greenhouse gas (GHG) emissions of Sinopharm Group decreased by 14.19%, showing that the company has made progress in taking action to reduce the climate impact of its operations.a
In 2024, the total Scope 1 emissions of Sinopharm Group were 48,785.71 metric tons of CO₂ equivalent (tCO₂e).a
Since 2022, Sinopharm Group's Scope 1 emissions have decreased by 6.96%, reflecting a declining long-term trend in Scope 1 emissions over time.ab
Compared to the previous year (2023), Sinopharm Group's Scope 1 emissions decreased by 10.84%, highlighting the company's efforts to lower direct emissions from assets it owns or controls.a
In 2024, Sinopharm Group reported Scope 2 greenhouse gas (GHG) emissions of 177,259.36 tCO₂e without specifying the calculation method.a
Since 2022, Sinopharm Group's Scope 2 greenhouse gas (GHG) emissions (Unspecified Calculation Method) have decreased by 11.67%, reflecting a declining long-term trend in Scope 2 emissions over time.ab
Compared to the previous year (2023), Sinopharm Group's Scope 2 emissions (Unspecified Calculation Method) fell by 15.07% in 2024, showing that the company has made progress in taking action to reduce the climate impact of its energy consumption.a
In 2024, Sinopharm Group reported its Scope 2 emissions using an unspecified methodology.a
In 2024, Sinopharm Group reported 318,336.83 metric tons of CO₂ equivalent (tCO₂e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain.a
The 2024 disclosure of Sinopharm Group includes a breakdown across 0 of the 15 Scope 3 categories defined by the GHG Protocol, matching the level of disclosure in 2023, demonstrating consistent Scope 3 emissions reporting coverage year over year.a
In 2024, Sinopharm Group reported total Scope 3 emissions of 318,336.83 metric tons of CO₂ equivalent (tCO₂e).a
In 2024, Sinopharm Group reported Scope 1 greenhouse gas (GHG) emissions of 48,785.71 tCO₂e and total revenues of USD 80,095 millions. This translates into an emissions intensity of 0.61 tCO₂e per millions USD.a
In 2024, Sinopharm Group reported a Scope 1 emissions intensity of 0.61 tCO₂e per millions USD. Compared to the peer group median of 1.04, this places the company below its industry benchmark, indicating it is more carbon-efficient than most competitors.a
In 2024, Sinopharm Group ranked 10 out of 22 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD).a
Sinopharm Group is therefore positioned in the mid-range of its industry, neither a clear leader nor a laggard in carbon efficiency.a
In 2024, Sinopharm Group reported a total carbon footprint of 544,381.9 metric tons of CO₂ equivalent (tCO₂e) across Scope 1, Scope 2, and Scope 3 emissions. This represents a 106.66% increase compared to 2023, suggesting a rise in emissions across its operations or value chain.a
The largest contributor to Sinopharm Group's total carbon footprint was Scope 3 emissions, accounting for 58.48% of the company's total carbon footprint, followed by Scope 2 emissions at 32.56%.a